Small-Cell Lung Cancer Market Report, Analysis, Overview, Therapeutics Development, profiles, Competitors : Ken Research

1

• Global Awareness In Small-Cell Lung Cancer To
  Boost Global Therapeutics Market Ken Research

2

• According to the study Small-Cell Lung Cancer -
  Pipeline Review, H1 2018, the market for small
  cell lung cancer treatment is geographically
  spread across Americas, Europe, and Asia Pacific
  excluding Japan, Japan and Middle East Africa.
  America accounts for better treatment options
  because it is a highly developed region with more
  healthcare facilities and more population are
  aware about small cell lung cancer. Asia Pacific
  and Europe countries are expecting a remarkable
  growth in the small cell lung cancer treatment
  market. According to World Health Organization
  (WHO) reports, more than 10 million people are
  affected with cancer which is one of the leading
  causes of death. The leading cancer type is lung
  cancer that accounts for the majority of the
  deaths. The leading key players of small-cell
  lung cancer market are AbbVie Inc, Advenchen
  Laboratories LLC, Aeglea BioTherapeutics Inc,
  Amgen Inc, Andarix Pharmaceuticals Inc, Aposense
  Ltd, Aprea AB, Ascentage Pharma Group Corp Ltd,
  Astellas Pharma Inc and others.

3

• Cancer occurs due to cell transformation where
  normal cells grow and multiply without control.
  The common cause of mortality and morbidity
  worldwide is lung cancer that is caused majorly
  due to smoking. Lung cancer is categorized into
  two types such as non-small cell lung cancer and
  small cell lung cancer. Small cell lung cancer is
  caused due to smoking tobacco, or second hand
  smoking, or on exposure to asbestos, chromium,
  arsenic, nickel, soot, or radon. The symptoms
  associated with lung cancer are chest pain,
  incurable cough, blood in sputum, fatigue, loss
  of appetite, unintentional weight loss, shortness
  of breath, and wheezing. Small cell lung cancer
  cannot be diagnosed at an early stage and can be
  diagnosed only at the late stage of disease
  progression leading to more number of deaths.
  Small cell lung cancer is recurrent in nature,
  spreads quickly and is difficult to cure at a go.
  This cancer usually starts in the breathing tubes
  (bronchi) in the center of the chest as tumors
  and often spread rapidly to the other parts of
  the human body, including brain, liver, and bone.
  

4

• The major risk factors for small cell lung cancer
  are modernization, smoking, increased alcohol
  consumption, unhealthy food, air pollution,
  chronic infections, family history of lung
  cancer, HIV, exposure to triggers and carcinogens
  such as radon gas, exposure to radioactive
  materials, air pollution and no physical activity
  are indirectly driving the global small cell lung
  cancer market. All the emerging economies are
  providing awareness among the people about the
  small cell lung cancer. Various available
  treatments for small cell lung cancer are
  surgery, radiation therapy and chemotherapy.
  Surgery is performed to remove malignant tumor
  and lymph node in lungs. Chemotherapy treatment
  is given at an early stage of small cell lung
  cancer. Radiation therapy is given to shrink
  tumor cells, to relieve symptoms such as
  bleeding, cough, trouble swallowing and shortness
  of breath. Three-dimensional conformal radiation
  therapy (3D-CRT) and Intensity modulated
  radiation therapy (IMRT) are the two types of
  radiation methods used in small cell lung cancer
  treatment.

5

• The pipeline review on small cell lung cancer
  market provides a comprehensive analysis on
  various key players, targeted therapeutics under
  development, drug target, mechanism of action
  (MoA), route of administration (RoA), molecule
  type, descriptive pharmacological action of the
  therapeutics, complete research and development
  history, summary of all the dormant and
  discontinued projects, latest news reports, press
  releases reports, thoughtful insights, facts,
  historical data, statistically supported
  industry-validated market data, a suitable set of
  assumptions and methodologies, geography,
  applications, market segments, market dynamics,
  market size, supply, demand, current
  trends/issues/challenges, competition,
  technology, value chain, in-depth analysis on new
  and available drugs, macro-economic indicators,
  governing factors along with market
  attractiveness, latest industry trends and
  developments. Global small cell lung cancer
  therapeutics market will witness an advance
  higher growth rate as compared to previous years
  due to increasing in instances of smoking, rising
  cases of lung infections, and increasing rate of
  lung cancers. Therefore, there will be an
  increasing demand for small cell lung cancer
  drugs over the next few years.

6

• To know more, click on the link below
• https//www.kenresearch.com/healthcare/pharmaceuti
  cals/small-cell-lung-cancer-pipeline-review-h1-201
  8/149556-91.html
• Related Reports-
• https//www.kenresearch.com/healthcare/pharmaceuti
  cals/small-cell-lung-cancer-pipeline/9984-91.html
• https//www.kenresearch.com/healthcare/pharmaceuti
  cals/small-cell-lung-cancer/42712-91.html
• Contact UsKen ResearchAnkur Gupta, Head
  Marketing Communications
• sales_at_kenresearch.com
• 91-9015378249

7
(No Transcript)